Screening for asymptomatic chlamydial infection is the key to reducing prevalence and sequelae of infection. Therefore, laboratory testing is an important element in a chlamydia and gonorrhea control program. The following resources are provided to assist health professionals in identifying "best practices" as it relates to laboratory testing technology and accompanying quality assurance activities.
Glossary of Terms
A comprehensive listing of laboratory definitions, including a quick reference to commonly used acronyms and abbreviations as well as a section on how to calculate disease distribution. The glossary was developed by the National Chlamydia Laboratory Coordinator, Richard Steece, PhD.
Download document (PDF, 119 KB)
National Chlamydia Laboratory Committee
The National Chlamydia Laboratory Committee (NCLC) was created in 1995 by laboratory members of the CDC National Infertility Prevention Project (IPP) in conjunction with the Centers for Disease Control and Prevention (CDC) to provide a forum for the laboratory subcommittees of the ten Regional Infertility Advisory Groups to discuss issues and concerns regarding chlamydia screening tests and to develop a common position acceptable to the Regions.
Click here to go to the NCLC introduction and table of contents.
Description of Chlamydia Test Technologies
